A Phase 1, Double-blind, Randomized, Placebo-controlled, Single- and Multiple-dose Escalating Study

NCT05021666 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

82

Enrollment

OTHER

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: Placebo
DRUG: PB 718

Sponsor

PegBio Co., Ltd.

Collaborators

[object Object]